Name
Vaccines
Accession Number
DBCAT002013
Description

Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.

ATC Classification
Drugs
DrugDrug Description
Varicella zoster vaccine (live/attenuated)Zostavax vaccine is indicated for the prevention of herpes zoster (shingles) in immunocompetent adults aged 50 years and older. Varivax vaccine is indicated for active immunization for the prevention of...
Yellow fever vaccineYellow Fever Vaccine is indicated for active immunization for the prevention of yellow fever in persons 9 months of age and older in the following categories: Persons Living in or...
Clostridium tetani toxoid antigen (formaldehyde inactivated)Clostridium tetani toxoid antigen (formaldehyde inactivated) is a vaccine for intramuscular injection. It is used for active immunization of children 7 years of age or older, and adults, for prevention...
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)Not Annotated
Rotavirus vaccineRotarix is indicated for prevention of rotavirus gastroenteritis caused by G1, G3, G4, and G9 types in infants aged 6-24 weeks [FDA Label]. Rotateq is indicated for the prevention of...
G17DTIntended for the treatment of various forms of cancer.
INGN 225Investigated for use/treatment in breast cancer, head and neck cancer, and lung cancer.
RindopepimutInvestigated for use/treatment in brain cancer.
SRP 299Investigated for use/treatment in asthma, atopic dermatitis, and pediatric atopic dermatitis indications.
GI-5005Investigated for use/treatment in hepatitis (viral, C).
TG4010Investigated for use/treatment in breast cancer, renal cell carcinoma, prostate cancer, and lung cancer.
Rabies virus inactivated antigen, ARabies virus inactivated antigen, A is an inactivated virus vacine for the intramuscular injection. It is an active immunization against rabies that can be administered pre- or post-exposure to the...
TecemotideTecemotide has been used in trials studying the treatment of Prostate Cancer and Carcinoma, Non-Small-Cell Lung.
BCG vaccineA vaccine indicated in the prevention of tuberculosis and the treatment of non-invasive urothelial bladder cancer.
Typhoid vaccineA vaccine used to prevent typhoid.
Rubella virus vaccineA vaccine used to prevent Rubella.
Anthrax immune globulin humanAn immunizing agent used for the treatment of inhalational anthrax in adult and pediatric patients in combination with antibacterial agents.
Bacillus calmette-guerin substrain tice live antigenA live attenuated vaccine against Mycobacterium bovis.
Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)Not Annotated
Typhoid Vi polysaccharide vaccineTyphoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for...
Bacillus calmette-guerin substrain connaught live antigenIndicated for intravesical use in the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder and for the prophylaxis of primary or recurrent stage Ta and/or T1...
Hepatitis A VaccineA live attenuated vaccine against infection with the Hepatitis A virus.
Typhoid Vaccine LiveSalmonella typhi Ty21a live antigen is a live attenuated vaccine for oral administration only. It contains the attenuated strain Salmonella typhi Ty21a. The vaccine prevents the development of typhoid fever,...
Rabies immune globulin, humanA solution of antibodies used to prevent rabies after an exposure.
Hepatitis B Vaccine (Recombinant)A solution of Hepatitis B surface antigen used to immunize patients against Hepatitis B.
Anthrax vaccineAnthrax vaccine is a vaccine used for the pre- or post-exposure prophylaxis of disease in at high risk of, suspected or confirmed exposure to Bacillus anthracis. It is subcutaneously or...
Bacillus calmette-guerin substrain danish 1331 live antigenBCG SSI has been used in trials studying Tuberculosis.
Vibrio cholerae CVD 103-HgR strain live antigenA live, attenuated vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1.
Human adenovirus e serotype 4 strain cl-68578 antigenHuman adenovirus e serotype 4 strain cl-68578 antigen is a vaccine.
Adenovirus type 7 vaccine liveNot Annotated
Smallpox (Vaccinia) Vaccine, LiveThe live antigen of the New York City Board of Health strain of Vaccinia is indicated (within the ACAM2000 formulation) for active immunization against smallpox disease in patients determined to...
Rabies virus inactivated antigen, BInactivated rabies virus antigen B is indicated for pre- and post-exposure prophylaxis against rabies.
PEV3AInvestigated for use/treatment in malaria.
VitespenInvestigated for use/treatment in kidney cancer, melanoma, renal cell carcinoma, lymphoma (unspecified), colorectal cancer, and brain cancer.
Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigenHaemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen is a vaccine for intramuscular injection used in the prevention of invasive disease caused by Haemophilus influenzae type...
Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigenHaemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen is a vaccine containing outer membrane antigen extracted from Haemophilus influenzae.
Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigenIndicated for active immunization in pediatric patients 15 months through 4 years of age as a booster dose for the prevention of invasive disease caused by Haemophilus influenzae type b.
Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigenA seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigenA seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)An influenza antigen used in seasonal influenza vaccines.
Pertussis vaccinePertussis vaccine is under investigation in clinical trial NCT01698346 (Pertussis (Tdap) Vaccination in Pregnancy).
Yersinia pestis 195/p antigen (formaldehyde inactivated)Yersinia pestis 195/p antigen (formaldehyde inactivated) is under investigation in clinical trial NCT02596308 (Immunogenicity and Safety of Subunit Plague Vaccine).
Varicella zoster vaccine (recombinant)Varicella zoster vaccine is indicated for the prevention of herpes zoster (HZ) (shingles) in adults aged 50 years and older and in adults aged 18 years and older who are...
Modified vaccinia ankaraModified vaccinia ankara is a vaccine indicated for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for...
Ebola Zaire vaccine (live, attenuated)A vaccine used in the prophylaxis of Ebola virus disease caused by the species of Zaire ebolaviruses.
Measles virus vaccine live attenuatedA vaccine used to prevent Measles.
Moderna COVID-19 VaccineAn mRNA vaccine for the prevention of COVID-19, the disease caused by the SARS-CoV-2 virus, in patients aged 18 years and older.
Influenza A virus A/Hong Kong/2671/2019 IVR-208 (H3N2) antigen (formaldehyde inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen (formaldehyde inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza B virus Yamagata lineage haemagglutinin, recombinantNot Annotated
Influenza B virus Victoria lineage haemagglutinin, recombinantNot Annotated
Influenza A virus subtype H1N1 haemagglutinin, recombinantNot Annotated
Influenza A virus subtype H3N2 haemagglutinin, recombinantNot Annotated
Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)Not Annotated
Bacillus calmette-guerin substrain russian BCG-I live antigenAn intravesically-administered live BCG vaccine used to treat papillary urothelial cell carcinoma of the bladder.
Janssen COVID-19 VaccineAn adenovirus-based vaccine used for active immunization against COVID-19 caused by SARS-CoV-2 infection.
Influenza A virus A/Tasmania/503/2020 IVR-221 (H3N2) antigen (formaldehyde inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza B virus B/Phuket/3073/2013 antigen (formaldehyde inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Wisconsin/588/2019 (H1N1) recombinant hemagglutinin antigenA seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza B virus B/Washington/02/2019 recombinant hemagglutinin antigenA seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Tasmania/503/2020 (H3N2) live (attenuated) antigenA seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Victoria/1/2020 (H1N1) live (attenuated) antigenNot Annotated
Tick-borne encephalitis vaccine (whole virus, inactivated)A whole inactivated viral vaccine against meningoencephalitis caused by the tick-borne encephalitis virus.
Pfizer-BioNTech COVID-19 VaccineAn mRNA vaccine for the prevention of COVID-19, the disease caused by the SARS-CoV-2 virus.
Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen (UV, formaldehyde inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Tasmania/503/2020 IVR-221 (H3N2) antigen (UV, formaldehyde inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen (propiolactone inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (propiolactone inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (formaldehyde inactivated)A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection...
Influenza A virus A/Tasmania/503/2020 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)In combination with other influenza virus subtypes A and types B strains, this Influenza A viral strain is used for active immunization of adults and children aged 6 months or...
Influenza A virus A/Washington/19/2020 (H1N1) antigen (MDCK cell derived, propiolactone inactivated)In combination with other influenza virus subtypes A and types B strains, this Influenza A viral strain is used for active immunization of adults and children aged 6 months or...
Influenza A virus A/Tasmania/503/2020 (H3N2) recombinant hemagglutinin antigenNot Annotated
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) is a vaccine that is used in the prophylaxis of Pertussis (whooping cough), which is caused by a small Gram-negative coccobacillus that infects...
Mumps virus strain B level jeryl lynn live antigenA vaccine used to prevent Mumps.
NuvaxovidA recombinant spike (S) protein vaccine for the prevention of COVID-19 caused by SARS-CoV-2.
Dengue tetravalent vaccine, liveNot Annotated
AstraZeneca COVID-19 VaccineA two-dose replication-deficient adenovirus vector vaccine used to prevent COVID-19 caused by SARS-CoV-2.
INO-4800INO-4800 is a DNA vaccine containing the full sequence for the SARS-CoV-2 Spike (S) protein in development for immunization against COVID-19. Early in vitro studies using HEK-293T cells demonstrated that...
BNT162b1 SARS-CoV-2 VaccineBNT162b1 is one of four advanced mRNA-based vaccines being developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002, L15007] BNT162b1 is a nucleoside modified mRNA (modRNA) vaccine encoding...
VPM1002The bacille Calmette-Guérin (BCG) vaccine protects against severe extrapulmonary forms of tuberculosis (TB) but does not adequately protect against pulmonary TB -- the most prevalent form of TB. This recombinant...
BBIBP-CorVBBIBP-CorV vaccine contains a SARS-CoV-2 strain inactivated inside Vero Cells. Investigation shows this vaccine induces neutralizing antibodies in several mammalian species while also showing protective efficacy with SARS-CoV-2 challenge in...
IMM-101IMM-101 is a heat-inactivated immune-activating mycobacterial product. It has shown to be safe and well tolerated to complement conventional cancer therapy for patients with melanoma and pancreatic ductal adenocarcinoma[A220013,A220018,A220023]. Studies...
Bizalimogene ralaplasmidBizalimogene ralaplasmid is under investigation in clinical trial NCT03499795 (VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 And/or HPV-18 Related Anal or Anal/peri-anal, High Grade...
PidacmeranPidacmeran is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).
BNT-162A1BNT-162A1 is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).
SARS-CoV-2 vaccineSARS-CoV-2 vaccine is an adjuvanted recombinant protein-based COVID-19 vaccine candidate being developed collaboratively by GlaxoSmithKline (GSK) and Sanofi[L30405, L30410, L30415]. This vaccine candidate is composed of a spike protein antigen...
EpiVacCoronaEpiVacCorona Vaccine, developed by the Vektor State Research Center of Virology and Biotechnology in Russia, is based on peptide-antigens that facilitate immunity to the SARS-CoV-2 virus . It is currently...
Plant-based virus-like particles, recombinant, adjuvanted COVID-19 vaccineA vaccine comprising purified SARS-CoV-2 spike protein expressed in plant-based virus-like particles for the prevention of COVID-19 in adult patients.
Drugs & Drug Targets
DrugTargetType
RindopepimutEpidermal growth factor receptortarget
TG4010Mucin-1target
TG4010Interleukin-2target
Anthrax immune globulin humanProtective antigentarget
Hepatitis A VaccineB-lymphocytestarget
Rabies immune globulin, humanRabies Virus Proteinstarget